1. Home
  2. BW vs MGNX Comparison

BW vs MGNX Comparison

Compare BW & MGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BW
  • MGNX
  • Stock Information
  • Founded
  • BW 1867
  • MGNX 2000
  • Country
  • BW United States
  • MGNX United States
  • Employees
  • BW N/A
  • MGNX N/A
  • Industry
  • BW Building Products
  • MGNX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BW Industrials
  • MGNX Health Care
  • Exchange
  • BW Nasdaq
  • MGNX Nasdaq
  • Market Cap
  • BW 119.1M
  • MGNX 99.7M
  • IPO Year
  • BW N/A
  • MGNX 2013
  • Fundamental
  • Price
  • BW $2.05
  • MGNX $1.70
  • Analyst Decision
  • BW Strong Buy
  • MGNX Hold
  • Analyst Count
  • BW 1
  • MGNX 5
  • Target Price
  • BW $5.00
  • MGNX $3.25
  • AVG Volume (30 Days)
  • BW 1.9M
  • MGNX 582.9K
  • Earning Date
  • BW 08-11-2025
  • MGNX 08-14-2025
  • Dividend Yield
  • BW N/A
  • MGNX N/A
  • EPS Growth
  • BW N/A
  • MGNX N/A
  • EPS
  • BW N/A
  • MGNX N/A
  • Revenue
  • BW $724,905,000.00
  • MGNX $165,495,000.00
  • Revenue This Year
  • BW N/A
  • MGNX N/A
  • Revenue Next Year
  • BW $8.02
  • MGNX N/A
  • P/E Ratio
  • BW N/A
  • MGNX N/A
  • Revenue Growth
  • BW 48.90
  • MGNX 303.47
  • 52 Week Low
  • BW $0.22
  • MGNX $0.99
  • 52 Week High
  • BW $2.99
  • MGNX $5.10
  • Technical
  • Relative Strength Index (RSI)
  • BW 77.66
  • MGNX 55.49
  • Support Level
  • BW $1.40
  • MGNX $1.63
  • Resistance Level
  • BW $1.83
  • MGNX $1.87
  • Average True Range (ATR)
  • BW 0.18
  • MGNX 0.13
  • MACD
  • BW 0.04
  • MGNX 0.02
  • Stochastic Oscillator
  • BW 95.65
  • MGNX 61.36

About BW Babcock & Wilcox Enterprises Inc.

Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.

About MGNX MacroGenics Inc.

Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. It's a pipeline of product candidates designed to target either various tumor-associated antigens or immune checkpoint molecules. The company has three proprietary product candidates in clinical development: lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload, and MGC028, an ADC that targets ADAM9 and delivers a novel TOP1i-based linker-payload.

Share on Social Networks: